International Association for the Study of Lung Cancer | IASLC

IASLC_covid19

 

ILCN-Exclusive-Big

Stunning Progress Achieved in Lung Cancer Treatment Over the Last Decade

Read the Article

Lung Cancer Staging Project

The IASLC Staging Project is a global effort to study and improve the current staging system for lung cancer, mesothelioma, thymic and esophageal cancer.

We are seeking volunteers to submit data on thoracic cancer patients diagnosed between January 1, 2011, and December 31, 2019 to a secure, electronic data capture system provided by Cancer Research And Biostatistics (CRAB) in Seattle, Washington.

Be a Part of It



Join Now - Become a Member

Join the only network of specialists working to conquer lung and thoracic cancers worldwide. As a member, you can collaborate with a global team of thoracic oncology experts and gain access to the latest, ground-breaking research in lung cancer prevention, detection and treatment.

Join Now

Journal of Thoracic Oncology

Lung and thoracic specialists count on the IASLC’s Journal of Thoracic Oncology to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal focusing on lung and thoracic cancers, the journal is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community.

Go to the Journal

IASLC News

May 20, 2020
Access to targeted therapies for lung cancer depends on accurate identification of patients’ biomarkers through molecular testing, but survey results published today in the Journal of Thoracic Oncology suggest that many international clinicians are unaware of evidence-based guidelines that support the use of molecular testing.
May 15, 2020
Lung cancerpatients are at heightened risk for COVID-19 and the reported high mortalityrate among lung cancer patients with COVID-19 has given pause to oncologistswho are faced with patients with not one, but two severe, life-threateningdiseases.
March 25, 2020
Lung cancer clinical trials supported by the pharmaceutical industry demonstrate no more bias compared to studies funded by other sources, according to a study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer.




View News Archive

Events

View Event Calendar

Virtual Library

IASLC Publications

From specialized atlases to our award-winning textbook, IASLC publications are an invaluable educational resource for the thoracic oncology community.

View Publications

On Nearly Every Continent, Our Members Are Working Toward a World Without Lung and Thoracic Cancers

Asset 4

At IASLC, Our Mission is

 To Conquer Thoracic Cancers Worldwide